Aktivitäten
-
📣 This year's World ADC Conference will feature in-depth discussions of our innovative ADC platforms. Ronald Elgersma, PhD, Director of Protein &…
📣 This year's World ADC Conference will feature in-depth discussions of our innovative ADC platforms. Ronald Elgersma, PhD, Director of Protein &…
Beliebt bei Ivo Grgic
-
𝗕𝗶𝗴 𝗠𝗼𝘃𝗲𝘀 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆: Takeda Pays $1.2B Upfront for Innovent 👇 Takeda Pharmaceutical has signed a blockbuster deal with China’s…
𝗕𝗶𝗴 𝗠𝗼𝘃𝗲𝘀 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆: Takeda Pays $1.2B Upfront for Innovent 👇 Takeda Pharmaceutical has signed a blockbuster deal with China’s…
Beliebt bei Ivo Grgic
-
𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦: Roche secures FDA approval for Gazyva®/Gazyvaro® (obinutuzumab) in lupus nephritis - offering a new, effective option for…
𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦: Roche secures FDA approval for Gazyva®/Gazyvaro® (obinutuzumab) in lupus nephritis - offering a new, effective option for…
Beliebt bei Ivo Grgic
Berufserfahrung
Ausbildung
Auszeichnungen/Preise
-
Merck PS Commercial Award
Merck
Merck Process Solutions Commercial Award
-
Best Young Investigator Talk
Small-animal image-guided radiotherapy symposium
«Best Young Investigator Talk» at the scientific symposium «Small animal precision image-guided radiotherapy», Lisbon 2018
Sprachen
-
German
Muttersprache oder zweisprachig
-
Croatian
Muttersprache oder zweisprachig
-
English
Verhandlungssicher
-
French
Grundkenntnisse
Weitere Aktivitäten von Ivo Grgic
-
Looking forward to representing Basilea Pharmaceutica at BIO Europe to connect with existing and potential partners in the anti-infective space!
Looking forward to representing Basilea Pharmaceutica at BIO Europe to connect with existing and potential partners in the anti-infective space!
Beliebt bei Ivo Grgic
-
Cool paper in Cell: CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success https://lnkd.in/ewPu3Yyz T…
Cool paper in Cell: CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success https://lnkd.in/ewPu3Yyz T…
Beliebt bei Ivo Grgic
-
𝗝&𝗝 𝗶𝗻 𝗧𝗮𝗹𝗸𝘀 𝘁𝗼 𝗔𝗰𝗾𝘂𝗶𝗿𝗲 𝗣𝗿𝗼𝘁𝗮𝗴𝗼𝗻𝗶𝘀𝘁 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀❗ Johnson & Johnson is in talks to acquire Protagonist…
𝗝&𝗝 𝗶𝗻 𝗧𝗮𝗹𝗸𝘀 𝘁𝗼 𝗔𝗰𝗾𝘂𝗶𝗿𝗲 𝗣𝗿𝗼𝘁𝗮𝗴𝗼𝗻𝗶𝘀𝘁 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀❗ Johnson & Johnson is in talks to acquire Protagonist…
Beliebt bei Ivo Grgic
-
Thrilled to share a major milestone - Leads Biolabs has entered into an exclusive global license agreement with Dianthus Therapeutics for LBL-047…
Thrilled to share a major milestone - Leads Biolabs has entered into an exclusive global license agreement with Dianthus Therapeutics for LBL-047…
Beliebt bei Ivo Grgic
-
Congratulations to Brandon Capital portfolio company CatalYm GmbH on this phenomenal clinical data presented at ESMO in bladder cancer. GDF15…
Congratulations to Brandon Capital portfolio company CatalYm GmbH on this phenomenal clinical data presented at ESMO in bladder cancer. GDF15…
Beliebt bei Ivo Grgic
-
Thrilled to join the Business Development team at Byondis and I look forward to attending BioEurope next month in Vienna! With fully integrated…
Thrilled to join the Business Development team at Byondis and I look forward to attending BioEurope next month in Vienna! With fully integrated…
Geteilt von Ivo Grgic
-
What was trending at EANM? 💡 Back from Barcelona, our experts share key takeaways that caught our attention in the field of targeted radiotherapy…
What was trending at EANM? 💡 Back from Barcelona, our experts share key takeaways that caught our attention in the field of targeted radiotherapy…
Beliebt bei Ivo Grgic
-
Excited to attend #BIOEurope and present Almirall’s vision and innovation in dermatology at the leading life sciences partnering event with 5,700+…
Excited to attend #BIOEurope and present Almirall’s vision and innovation in dermatology at the leading life sciences partnering event with 5,700+…
Beliebt bei Ivo Grgic
-
Boehringer Ingelheim is proud to announce a new partnership with Aimed Bio Inc. on an exciting asset in the Antibody Drug Conjugate space. Many…
Boehringer Ingelheim is proud to announce a new partnership with Aimed Bio Inc. on an exciting asset in the Antibody Drug Conjugate space. Many…
Beliebt bei Ivo Grgic
-
📣Our Chief Business Officer, Dr. Christoph Korpus, MBA, will be speaking at the 2025 BioCentury BayHelix China Healthcare Summit on October 23rd in…
📣Our Chief Business Officer, Dr. Christoph Korpus, MBA, will be speaking at the 2025 BioCentury BayHelix China Healthcare Summit on October 23rd in…
Beliebt bei Ivo Grgic
-
We are excited to share the positive Phase 1 data on our novel anchored immunotherapy, tolododekin alfa (ANK-101), have been published in Nature…
We are excited to share the positive Phase 1 data on our novel anchored immunotherapy, tolododekin alfa (ANK-101), have been published in Nature…
Beliebt bei Ivo Grgic
-
🔬 With rising sample complexity, tighter budgets & demand for high-quality biologics, scientists face more pressure than ever to innovate…
🔬 With rising sample complexity, tighter budgets & demand for high-quality biologics, scientists face more pressure than ever to innovate…
Beliebt bei Ivo Grgic
-
🌟 Exciting News! 🌟 I’m thrilled to share that I’ve joined #Biosynth as Head of Business Development! #Biosynth is a global, innovative and…
🌟 Exciting News! 🌟 I’m thrilled to share that I’ve joined #Biosynth as Head of Business Development! #Biosynth is a global, innovative and…
Beliebt bei Ivo Grgic
-
Immunology at an inflection point: there are opportunities & challenges for innovators seeking growth in an unforgiving market Feel free to reach…
Immunology at an inflection point: there are opportunities & challenges for innovators seeking growth in an unforgiving market Feel free to reach…
Beliebt bei Ivo Grgic
-
It was great to see you again and attending some really interesting talks together.
It was great to see you again and attending some really interesting talks together.
Beliebt bei Ivo Grgic
Weitere ähnliche Profile
Weitere Mitglieder, die Ivo Grgic heißen
-
Ivo Grgic
Global Purchasing Category Manager Surfactants
-
Ivo Grgic
University professor at University of Zagreb, Faculty of Agriculture
-
Ivo Grgic
A human interested in people.
-
Ivo Grgic
CEO at İTÜ Çekirdek
Es gibt auf LinkedIn 17 weitere Personen, die Ivo Grgic heißen.
Weitere Mitglieder anzeigen, die Ivo Grgic heißen